Moreover, five out of seven non-HR T-ALL patients showed signs of CRLF2 overexpression, which has also been demonstrated as a poor prognostic marker in children with T-ALL [27]. This evidence concerns the gene CRLF2 and acute lymphoblastic leukemia.